Study S000315

Effects of Exenatide on Body Weight in Patients With Hypothalamic Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01484873
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 10
Start: 2012-06
Primary completion: 2015-03
Lead sponsor: Vanderbilt University Medical Center
Conditions: Obesity; Overweight; Craniopharyngioma
Interventions: DRUG:Exenatide
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Body Weight (kg) [baseline, 50 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0025613	A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity. Lomenick JP, Obesity (Silver Spring, Md.)	2016	Other trial	PMID 27133664 DOI	cites ClinicalTrials.gov:NCT01484873; registry reference RESULT:27133664